Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02860156 · ClinicalTrials.gov registry record
Characterizing HIV-related Diastolic Dysfunction
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 195
- Enrollment target
NCT02860156 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 195 participants.
The verdict
NCT02860156 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 195 participants
- Enrollment target
Study Summary
This is a multicenter clinical trial of a cross section of HIV+ patients with and without diastolic dysfunction. Approximately 200 HAART-treated virally suppressed HIV+ subjects (100 HIV+/DD+ \& 100 HIV+/DD-) will be enrolled. This study will evaluate biomarkers, phenomapping, metabolomics, cMRI, echocardiography to determine characteristics unique to this patient population.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2016-11-15 |
| Est. Completion | 2018-02-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02860156
The ClinicalTrials.gov registry entry for NCT02860156 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 195 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02860156 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02860156 about?
NCT02860156 is a clinical study titled "Characterizing HIV-related Diastolic Dysfunction". This is a multicenter clinical trial of a cross section of HIV+ patients with and without diastolic dysfunction. Approximately 200 HAART-treated virally suppressed HIV+ subjects (100 HIV+/DD+ \& 100 HIV+/DD-) will be enrolled. This study will evaluate biomarkers, phenomapping, metabolomics, cMRI, ec...
What is the current status of trial NCT02860156?
This trial is currently completed. The enrollment target is 195 participants. The study started on 2016-11-15. Estimated completion is 2018-02-09.
Who is sponsoring clinical trial NCT02860156?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.